AllStripes Announces $50 Million in Series B Funding to Advance Rare Disease Research

November 16, 2021

AllStripes has raised $50 million in Series B Funding, led by Lux Capital. As a result, the organization has initiated more than 100 programs to investigate rare diseases and to improve patient outcomes.

AllStripes CEO and Co-Founder Nancy Yu remarks, “Beginning research on a rare condition can feel like being dropped into a new world without a map and we are on a mission to change that with data,” adding, “This investment will allow us to better support the rare disease community, where each person’s experience is essential to understanding disease progression — ultimately leading to new treatments for rare disease patients around the globe.” Read more here.

(Source: AllStripes, 8/24/21)

Share This Story!